Editas Medicine (EDIT) Stock: Charts & Financials

Editas Medicine, Inc.(EDIT)

Biotechnology · Cambridge, MA

$2.81+0.02 (+0.54%)

Delayed quote: Oct 6, 2026, 3:05 PM EDT

About Editas Medicine, Inc.

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. Its lead program is EDIT-401, a one-time therapy designed to reduce LDL cholesterol through the upregulation of the LDL receptor to treat hyperlipidemia. The company also develops therapies to treat Sickle cell disease and transfusion-dependent beta thalassemia; and in vivo gene editing medicines indicated for other cells and tissues. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors, and autoimmune disease. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.

Cambridge, MA

87 employees

www.editasmedicine.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Gilmore O'Neill

View full financials

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	47.01M	11.89M	2.83M	24.74M	7.54M	3.58M	4.66M	30.60M	61K
Cost of Goods Sold	20.26M	0.00	483K	0.00	19.77M	16.18M	26.59M	48.61M	1.60M
Gross Profit	26.75M	11.89M	2.35M	24.74M	-12.23M	-12.60M	-21.93M	-18.01M	-1.54M
Gross Profit Margin	56.9%	100.0%	82.9%	100.0%	-162.2%	-352.2%	-470.9%	-58.8%	-2521.3%
Total Operating Expenses	108.87M	30.44M	27.35M	38.76M	12.32M	38.94M	54.23M	28.59M	64.13M
Research & Development	70.19M	20.18M	2.83M	27.40M	19.77M	16.18M	26.59M	48.61M	47.64M
Selling, General & Administrative	45.51M	11.60M	10.23M	11.35M	12.32M	12.86M	13.38M	16.35M	18.09M
Operating Income (EBIT)	-82.12M	-18.55M	-25.00M	-14.02M	-24.55M	-51.54M	-76.16M	-46.59M	-65.67M
Operating Margin	-174.7%	-156.0%	-883.2%	-56.7%	-325.4%	-1440.6%	-1635.1%	-152.2%	-107649.2%
Income Before Tax (EBT)	-73.95M	-18.23M	-24.98M	-5.62M	-25.12M	-53.23M	-76.09M	-45.40M	-62.14M
Interest Income	-3.60M	N/A	1.21M	-6.63M	1.83M	2.09M	2.72M	1.20M	3.53M
Interest Expense	-2.10M	1.06M	1.07M	-6.63M	2.40M	2.02M	2.22M	N/A	N/A
Other Income/Expense	8.17M	324K	21K	8.40M	-569K	-1.69M	75K	1.20M	3.52M
Net Income	-73.95M	-18.23M	-24.98M	-5.62M	-25.12M	-53.23M	-76.09M	-45.40M	-62.14M
Income Tax Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit Margin	-157.3%	-153.3%	-882.4%	-22.7%	-333.0%	-1487.8%	-1633.5%	-148.3%	-101870.5%
EBITDA	-79.70M	-18.14M	-24.52M	-13.21M	-23.83M	-49.71M	-74.25M	-45.21M	-64.07M
EBITDA Margin	-169.5%	-152.5%	-866.1%	-53.4%	-315.9%	-1389.3%	-1593.9%	-147.7%	-105027.9%
Depreciation & Amortization	2.42M	416K	483K	805K	721K	1.83M	1.92M	1.38M	1.60M
EPS Basic	-0.75	-0.15	-0.26	-0.06	-0.28	-0.63	-0.92	-0.55	-0.75
EPS Diluted	-0.75	-0.15	-0.26	-0.06	-0.28	-0.63	-0.92	-0.55	-0.75
Weighted Average Basic Shares	119.29M	119.29M	97.88M	88.75M	90.09M	84.41M	83.06M	82.61M	82.49M
Weighted Average Diluted Shares	119.29M	119.29M	97.88M	88.75M	90.09M	84.41M	83.06M	82.61M	82.49M

Quarterly Report

TTM

Quarter ended Jun 2026

Quarter ended Mar 2026

Quarter ended Dec 2025

Quarter ended Sep 2025

Quarter ended Jun 2025

Quarter ended Mar 2025

Quarter ended Dec 2024

Quarter ended Sep 2024

Revenue

47.01M

11.89M

2.83M

24.74M

7.54M

3.58M

4.66M

30.60M

61K

Cost of Goods Sold

20.26M

0.00

483K

0.00

19.77M

16.18M

26.59M

48.61M

1.60M

Gross Profit

26.75M

11.89M

2.35M

24.74M

-12.23M

-12.60M

-21.93M

-18.01M

-1.54M

Gross Profit Margin

56.9%

100.0%

82.9%

100.0%

-162.2%

-352.2%

-470.9%

-58.8%

-2521.3%

Total Operating Expenses

108.87M

30.44M

27.35M

38.76M

12.32M

38.94M

54.23M

28.59M

64.13M

Research & Development

70.19M

20.18M

2.83M

27.40M

19.77M

16.18M

26.59M

48.61M

47.64M

Selling, General & Administrative

45.51M

11.60M

10.23M

11.35M

12.32M

12.86M

13.38M

16.35M

18.09M

Operating Income (EBIT)

-82.12M

-18.55M

-25.00M

-14.02M

-24.55M

-51.54M

-76.16M

-46.59M

-65.67M

Operating Margin

-174.7%

-156.0%

-883.2%

-56.7%

-325.4%

-1440.6%

-1635.1%

-152.2%

-107649.2%

Income Before Tax (EBT)

-73.95M

-18.23M

-24.98M

-5.62M

-25.12M

-53.23M

-76.09M

-45.40M

-62.14M

Interest Income

-3.60M

N/A

1.21M

-6.63M

1.83M

2.09M

2.72M

1.20M

3.53M

Interest Expense

-2.10M

1.06M

1.07M

-6.63M

2.40M

2.02M

2.22M

N/A

Other Income/Expense

8.17M

324K

21K

8.40M

-569K

-1.69M

75K

1.20M

3.52M

Net Income

-73.95M

-18.23M

-24.98M

-5.62M

-25.12M

-53.23M

-76.09M

-45.40M

-62.14M

Income Tax Expense

0.00

Net Profit Margin

-157.3%

-153.3%

-882.4%

-22.7%

-333.0%

-1487.8%

-1633.5%

-148.3%

-101870.5%

EBITDA

-79.70M

-18.14M

-24.52M

-13.21M

-23.83M

-49.71M

-74.25M

-45.21M

-64.07M

EBITDA Margin

-169.5%

-152.5%

-866.1%

-53.4%

-315.9%

-1389.3%

-1593.9%

-147.7%

-105027.9%

Depreciation & Amortization

2.42M

416K

483K

805K

721K

1.83M

1.92M

1.38M

1.60M

EPS Basic

-0.75

-0.15

-0.26

-0.06

-0.28

-0.63

-0.92

-0.55

-0.75

EPS Diluted

-0.75

-0.15

-0.26

-0.06

-0.28

-0.63

-0.92

-0.55

-0.75

Weighted Average Basic Shares

119.29M

97.88M

88.75M

90.09M

84.41M

83.06M

82.61M

82.49M

Weighted Average Diluted Shares

119.29M

97.88M

88.75M

90.09M

84.41M

83.06M

82.61M

82.49M

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	40.52M	32.31M	78.12M	19.71M	25.54M	90.73M	20.53M	31.94M
Cost of Goods Sold	0.00	199.25M	6.06M	6.34M	5.05M	158.00M	96.90M	90.65M
Gross Profit	40.52M	-166.93M	72.06M	13.38M	20.49M	-67.26M	-76.37M	-58.72M
Gross Profit Margin	100.0%	-516.6%	92.2%	67.9%	80.2%	-74.1%	-372.0%	-183.9%
Total Operating Expenses	139.86M	84.22M	241.24M	239.32M	213.64M	67.58M	64.56M	145.66M
Research & Development	89.95M	199.25M	177.65M	174.96M	142.51M	158.00M	96.90M	90.65M
Selling, General & Administrative	49.90M	71.99M	69.65M	70.70M	76.18M	67.58M	64.56M	55.01M
Operating Income (EBIT)	-99.34M	-251.15M	-169.18M	-225.95M	-193.15M	-134.84M	-140.92M	-113.73M
Operating Margin	-245.2%	-777.2%	-216.6%	-1146.3%	-756.1%	-148.6%	-686.4%	-356.1%
Income Before Tax (EBT)	-160.06M	-237.09M	-153.22M	-220.43M	-192.50M	-115.98M	-133.75M	-109.95M
Interest Income	8.31M	14.06M	17.57M	5.52M	607K	2.60M	7.31M	3.44M
Interest Expense	6.17M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Other Income/Expense	-60.72M	14.06M	15.96M	5.52M	644K	18.86M	7.18M	3.77M
Net Income	-160.06M	-237.09M	-153.22M	-220.43M	-192.50M	-115.98M	-133.75M	-109.95M
Income Tax Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit Margin	-395.0%	-733.7%	-196.1%	-1118.3%	-753.6%	-127.8%	-651.4%	-344.3%
EBITDA	-94.06M	-245.34M	-163.12M	-219.61M	-188.09M	-130.88M	-138.09M	-110.47M
EBITDA Margin	-232.1%	-759.2%	-208.8%	-1114.1%	-736.3%	-144.3%	-672.6%	-345.9%
Depreciation & Amortization	5.28M	5.81M	6.06M	6.34M	5.05M	3.96M	2.83M	3.25M
EPS Basic	-1.80	-2.88	-2.02	-3.21	-2.85	-1.98	-2.47	-2.33
EPS Diluted	-1.80	-2.88	-2.02	-3.21	-2.85	-1.98	-2.47	-2.33
Weighted Average Basic Shares	88.75M	82.34M	75.97M	68.66M	67.62M	58.61M	49.98M	47.10M
Weighted Average Diluted Shares	88.75M	82.34M	75.97M	68.66M	67.62M	58.61M	49.98M	47.10M

Annual Report

12/31/2025

12/31/2024

12/31/2023

12/31/2022

12/31/2021

12/31/2020

12/31/2019

12/31/2018

Revenue

40.52M

32.31M

78.12M

19.71M

25.54M

90.73M

20.53M

31.94M

Cost of Goods Sold

0.00

199.25M

6.06M

6.34M

5.05M

158.00M

96.90M

90.65M

Gross Profit

40.52M

-166.93M

72.06M

13.38M

20.49M

-67.26M

-76.37M

-58.72M

Gross Profit Margin

100.0%

-516.6%

92.2%

67.9%

80.2%

-74.1%

-372.0%

-183.9%

Total Operating Expenses

139.86M

84.22M

241.24M

239.32M

213.64M

67.58M

64.56M

145.66M

Research & Development

89.95M

199.25M

177.65M

174.96M

142.51M

158.00M

96.90M

90.65M

Selling, General & Administrative

49.90M

71.99M

69.65M

70.70M

76.18M

67.58M

64.56M

55.01M

Operating Income (EBIT)

-99.34M

-251.15M

-169.18M

-225.95M

-193.15M

-134.84M

-140.92M

-113.73M

Operating Margin

-245.2%

-777.2%

-216.6%

-1146.3%

-756.1%

-148.6%

-686.4%

-356.1%

Income Before Tax (EBT)

-160.06M

-237.09M

-153.22M

-220.43M

-192.50M

-115.98M

-133.75M

-109.95M

Interest Income

8.31M

14.06M

17.57M

5.52M

607K

2.60M

7.31M

3.44M

Interest Expense

6.17M

N/A

Other Income/Expense

-60.72M

14.06M

15.96M

5.52M

644K

18.86M

7.18M

3.77M

Net Income

-160.06M

-237.09M

-153.22M

-220.43M

-192.50M

-115.98M

-133.75M

-109.95M

Income Tax Expense

0.00

Net Profit Margin

-395.0%

-733.7%

-196.1%

-1118.3%

-753.6%

-127.8%

-651.4%

-344.3%

EBITDA

-94.06M

-245.34M

-163.12M

-219.61M

-188.09M

-130.88M

-138.09M

-110.47M

EBITDA Margin

-232.1%

-759.2%

-208.8%

-1114.1%

-736.3%

-144.3%

-672.6%

-345.9%

Depreciation & Amortization

5.28M

5.81M

6.06M

6.34M

5.05M

3.96M

2.83M

3.25M

EPS Basic

-1.80

-2.88

-2.02

-3.21

-2.85

-1.98

-2.47

-2.33

EPS Diluted

-1.80

-2.88

-2.02

-3.21

-2.85

-1.98

-2.47

-2.33

Weighted Average Basic Shares

88.75M

82.34M

75.97M

68.66M

67.62M

58.61M

49.98M

47.10M

Weighted Average Diluted Shares

88.75M

82.34M

75.97M

68.66M

67.62M

58.61M

49.98M

47.10M

Income Statement

Quarterly Income Statement (USD)

Annual Income Statement (USD)